PXD101
| PXD101 | |
|---|---|
| Term | PXD101 |
| Short definition | PXD101 - A drug used to treat adults with peripheral T-cell lymphoma that has come back or has not improved with other treatments. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
PXD101 - A drug used to treat adults with peripheral T-cell lymphoma that has come back or has not improved with other treatments. It is also being studied in the treatment of other types of cancer. PXD101 blocks certain enzymes needed for cell division and can kill cancer cells. It can also prevent the growth of new blood vessels that tumors need to grow and may help make cancer cells easier to kill with other cancer drugs. It's a type of histone deacetylase inhibitor, a type of anti-angiogenesis agent, and a type of chemosensitizer. Also called Beleodaq and Belinostat
External links
- Medical encyclopedia article on PXD101
- Wikipedia's article - PXD101
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski